STOCK TITAN

OKYO Pharma Limited (OKYO) Net Income by Year

OKYO

OKYO Pharma Limited reported a net loss of $4.7M in fiscal year 2025. The table below carries 6 fiscal years, from 2020 to 2025, and the quarters OKYO Pharma Limited has filed alongside them.

FY2025 annual
Net Income -$4.7M
Source SEC Filings (10-K/10-Q) Latest period FY2025, ended Mar 31, 2025 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

OKYO Net Income by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-K
Net Income-$4.7MN/A-$13.3M-144.4%-$5.4M-62.0%-$3.4M-117.2%-$1.5M

OKYO Net Income by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ4'2510-KQ4'2410-KQ4'2310-KQ4'2210-KQ4'2110-K
Net IncomeN/AN/AN/AN/AN/A

What net income means

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.

More OKYO Pharma Limited financials

Frequently Asked Questions

What was OKYO Pharma Limited's net income in fiscal year 2025?

OKYO Pharma Limited reported a net loss of $4.7M in fiscal year 2025.

How has OKYO Pharma Limited's net income changed over the years?

Across the 6 fiscal years this page covers, OKYO Pharma Limited (OKYO) net income went from -$1.5M in fiscal year 2020 to -$4.7M in fiscal year 2025.

What does net income mean on a financial statement?

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what OKYO Pharma Limited (OKYO) reported on that line in every period on record.